Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126634661 | 12663466 | 1 | I | 20160621 | 20160806 | 20160818 | 20160818 | EXP | GB-MHRA-EYC 00143249 | GB-TEVA-683487ACC | TEVA | 19.00 | YR | M | Y | 78.00000 | KG | 20160818 | CN | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126634661 | 12663466 | 1 | PS | FEXOFENADINE | FEXOFENADINEFEXOFENADINE HYDROCHLORIDE | 1 | Oral | Y | U | 76191 | 120 | MG | |||||||
| 126634661 | 12663466 | 2 | C | LORATADINE. | LORATADINE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126634661 | 12663466 | 1 | Seasonal allergy |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126634661 | 12663466 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126634661 | 12663466 | Dizziness | |
| 126634661 | 12663466 | Dyspnoea | |
| 126634661 | 12663466 | Loss of consciousness | |
| 126634661 | 12663466 | Throat tightness |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126634661 | 12663466 | 1 | 20160620 | 20160628 | 0 |